| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
56,440 |
45,901 |
$1.08M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,520 |
11,491 |
$130K |
| 64483 |
|
2,188 |
1,516 |
$108K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,354 |
2,352 |
$48K |
| 64635 |
|
526 |
293 |
$35K |
| 64636 |
|
836 |
293 |
$27K |
| 64493 |
|
595 |
356 |
$26K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
435 |
389 |
$23K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
5,708 |
3,597 |
$20K |
| 80305 |
|
2,730 |
2,319 |
$19K |
| L0637 |
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
67 |
50 |
$12K |
| 64494 |
|
594 |
355 |
$10K |
| G0396 |
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes |
822 |
717 |
$7K |
| 99152 |
|
588 |
410 |
$5K |
| 62321 |
|
98 |
64 |
$5K |
| 64495 |
|
307 |
171 |
$4K |
| 99490 |
Ccm add 20min |
1,579 |
1,441 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
341 |
275 |
$2K |
| 72275 |
|
119 |
69 |
$2K |
| 99205 |
Prolong outpt/office vis |
35 |
29 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
209 |
94 |
$2K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
468 |
342 |
$1K |
| 96103 |
|
136 |
117 |
$1K |
| 99215 |
Prolong outpt/office vis |
40 |
39 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
276 |
194 |
$967.66 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
4,915 |
3,159 |
$583.56 |
| 77002 |
|
42 |
27 |
$500.28 |
| 99442 |
|
51 |
36 |
$310.23 |
| 81025 |
|
121 |
106 |
$304.90 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
270 |
230 |
$282.24 |
| 20610 |
|
24 |
15 |
$275.01 |
| 96160 |
|
36 |
27 |
$110.38 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
587 |
411 |
$70.43 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
216 |
165 |
$45.61 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
198 |
148 |
$8.15 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
16 |
16 |
$0.00 |
| 1111F |
|
35 |
32 |
$0.00 |
| 1036F |
|
29 |
26 |
$0.00 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
14 |
13 |
$0.00 |
| 99401 |
|
51 |
49 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
51 |
46 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
13 |
12 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
35 |
32 |
$0.00 |